s6y
Company name or ticker
Search
Oncotelic Therapeutics, Inc.
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Filed
Tuesday, April 3, 2012
Accession number
0001193125-12-148094
Documents
Post-Effective Amendment No. 1 to Form S-1
POS AM
Certifications, consents and other formalities
1
Consent of Ernst & Young LLP
23.1
Consent of Ernst & Young LLP
EX-23.1
On sec.gov
Filing index
All files
Complete submission text
SGML header